# AES Corp: financial statements, quarterly

AES · NYSE · CIK 874761 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aes.md) · [Financials](/companies/aes/financials.md) · [Filings](/companies/aes/filings.md) · [Insiders](/companies/aes/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aes/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,434](/filings/0000874761-24-000070.md) | [2,968 d](/filings/0000874761-26-000063.md) | [3,085](/filings/0000874761-25-000035.md) | [2,942](/filings/0000874761-25-000075.md) | [3,289](/filings/0000874761-25-000084.md) | [2,962 d](/filings/0000874761-26-000063.md) | [2,926](/filings/0000874761-26-000120.md) | [2,855](/filings/0000874761-26-000144.md) | [3,351](/filings/0000874761-25-000084.md) | [3,101 d](/filings/0000874761-26-000063.md) | [3,180](/filings/0000874761-26-000120.md) | [3,422](/filings/0000874761-26-000144.md) |
| Cost of revenue | $m | [2,516](/filings/0000874761-24-000070.md) | [2,474 d](/filings/0000874761-26-000063.md) | [2,466](/filings/0000874761-25-000035.md) | [2,389](/filings/0000874761-25-000075.md) | [2,567](/filings/0000874761-25-000084.md) | [2,542 d](/filings/0000874761-26-000063.md) | [2,485](/filings/0000874761-26-000120.md) | [2,402](/filings/0000874761-26-000144.md) | [2,616](/filings/0000874761-25-000084.md) | [2,519 d](/filings/0000874761-26-000063.md) | [2,540](/filings/0000874761-26-000120.md) | [2,730](/filings/0000874761-26-000144.md) |
| Gross profit | $m | [918](/filings/0000874761-24-000070.md) | [494 d](/filings/0000874761-26-000063.md) | [619](/filings/0000874761-25-000035.md) | [553](/filings/0000874761-25-000075.md) | [722](/filings/0000874761-25-000084.md) | [420 d](/filings/0000874761-26-000063.md) | [441](/filings/0000874761-26-000120.md) | [453](/filings/0000874761-26-000144.md) | [735](/filings/0000874761-25-000084.md) | [582 d](/filings/0000874761-26-000063.md) | [640](/filings/0000874761-26-000120.md) | [692](/filings/0000874761-26-000144.md) |
| Interest expense | $m | [326](/filings/0000874761-24-000070.md) | [353 d](/filings/0000874761-26-000063.md) | [357](/filings/0000874761-25-000035.md) | [389](/filings/0000874761-25-000075.md) | [379](/filings/0000874761-25-000084.md) | [360 d](/filings/0000874761-26-000063.md) | [342](/filings/0000874761-26-000120.md) | [352](/filings/0000874761-26-000144.md) | [348](/filings/0000874761-25-000084.md) | [365 d](/filings/0000874761-26-000063.md) | [353](/filings/0000874761-26-000120.md) | [368](/filings/0000874761-26-000144.md) |
| Income tax | $m | [109](/filings/0000874761-24-000070.md) | [82.0 d](/filings/0000874761-26-000063.md) | [(16.0)](/filings/0000874761-25-000035.md) | [(35.0)](/filings/0000874761-25-000075.md) | [103](/filings/0000874761-25-000084.md) | [7.0 d](/filings/0000874761-26-000063.md) | [17.0](/filings/0000874761-26-000120.md) | [167](/filings/0000874761-26-000144.md) | [(226)](/filings/0000874761-25-000084.md) | [(139) d](/filings/0000874761-26-000063.md) | [(41.0)](/filings/0000874761-26-000120.md) | [28.0](/filings/0000874761-26-000144.md) |
| Net income | $m | [231](/filings/0000874761-24-000070.md) | [(94.0) d](/filings/0000874761-26-000063.md) | [432](/filings/0000874761-25-000035.md) | [276](/filings/0000874761-25-000075.md) | [504](/filings/0000874761-25-000084.md) | [467 d](/filings/0000874761-26-000063.md) | [46.0](/filings/0000874761-26-000144.md) | [(95.0)](/filings/0000874761-26-000144.md) | [639](/filings/0000874761-25-000084.md) | [320 d](/filings/0000874761-26-000063.md) | [487](/filings/0000874761-26-000144.md) | [426](/filings/0000874761-26-000144.md) |
| Diluted EPS | $ per share | [0.32](/filings/0000874761-24-000070.md) | not reported | [0.60](/filings/0000874761-25-000035.md) | [0.39](/filings/0000874761-25-000075.md) | [0.71](/filings/0000874761-25-000084.md) | not reported | [0.07](/filings/0000874761-26-000120.md) | [(0.15)](/filings/0000874761-26-000144.md) | [0.89](/filings/0000874761-25-000084.md) | not reported | [0.68](/filings/0000874761-26-000120.md) | [0.60](/filings/0000874761-26-000144.md) |
| Basic EPS | $ per share | [0.34](/filings/0000874761-24-000070.md) | not reported | [0.62](/filings/0000874761-25-000035.md) | [0.40](/filings/0000874761-25-000075.md) | [0.71](/filings/0000874761-25-000084.md) | not reported | [0.07](/filings/0000874761-26-000120.md) | [(0.15)](/filings/0000874761-26-000144.md) | [0.89](/filings/0000874761-25-000084.md) | not reported | [0.68](/filings/0000874761-26-000120.md) | [0.60](/filings/0000874761-26-000144.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.8](/filings/0000874761-23-000080.md) | [1.4](/filings/0000874761-25-000013.md) | [2.0](/filings/0000874761-24-000038.md) | [1.8](/filings/0000874761-25-000013.md) | [1.9](/filings/0000874761-25-000013.md) | [1.5](/filings/0000874761-26-000063.md) | [1.8](/filings/0000874761-25-000035.md) | [1.4](/filings/0000874761-25-000075.md) | [1.8](/filings/0000874761-25-000084.md) | [1.4](/filings/0000874761-26-000144.md) | [1.6](/filings/0000874761-26-000120.md) | [1.8](/filings/0000874761-26-000144.md) |
| Current assets | $bn | [7.3](/filings/0000874761-23-000080.md) | [6.6](/filings/0000874761-26-000063.md) | [7.2](/filings/0000874761-24-000038.md) | [9.7](/filings/0000874761-25-000013.md) | [10.7](/filings/0000874761-25-000013.md) | [6.8](/filings/0000874761-26-000063.md) | [7.9](/filings/0000874761-25-000035.md) | [6.3](/filings/0000874761-25-000075.md) | [6.8](/filings/0000874761-25-000084.md) | [6.5](/filings/0000874761-26-000144.md) | [6.1](/filings/0000874761-26-000120.md) | [6.4](/filings/0000874761-26-000144.md) |
| Total assets | $bn | [43.2](/filings/0000874761-23-000080.md) | [44.8](/filings/0000874761-26-000063.md) | [47.0](/filings/0000874761-24-000038.md) | [47.9](/filings/0000874761-25-000013.md) | [50.3](/filings/0000874761-25-000013.md) | [47.4](/filings/0000874761-26-000063.md) | [48.6](/filings/0000874761-25-000035.md) | [48.5](/filings/0000874761-25-000075.md) | [50.8](/filings/0000874761-25-000084.md) | [51.8](/filings/0000874761-26-000144.md) | [52.8](/filings/0000874761-26-000120.md) | [54.2](/filings/0000874761-26-000144.md) |
| Current liabilities | $bn | [8.8](/filings/0000874761-23-000080.md) | [9.7](/filings/0000874761-25-000013.md) | [9.2](/filings/0000874761-24-000038.md) | [9.8](/filings/0000874761-25-000013.md) | [12.4](/filings/0000874761-25-000013.md) | [8.6](/filings/0000874761-26-000063.md) | [9.3](/filings/0000874761-25-000035.md) | [7.7](/filings/0000874761-25-000075.md) | [9.4](/filings/0000874761-25-000084.md) | [8.5](/filings/0000874761-26-000144.md) | [8.4](/filings/0000874761-26-000120.md) | [8.6](/filings/0000874761-26-000144.md) |
| Shareholders' equity | $bn | [2.8](/filings/0000874761-23-000080.md) | [2.5](/filings/0000874761-25-000013.md) | [2.9](/filings/0000874761-24-000038.md) | [3.2](/filings/0000874761-25-000013.md) | [3.4](/filings/0000874761-25-000013.md) | [3.6](/filings/0000874761-26-000063.md) | [3.5](/filings/0000874761-25-000035.md) | [3.4](/filings/0000874761-25-000075.md) | [3.9](/filings/0000874761-25-000084.md) | [4.1](/filings/0000874761-26-000144.md) | [4.4](/filings/0000874761-26-000120.md) | [4.9](/filings/0000874761-26-000144.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,122 d](/filings/0000874761-24-000070.md) | [725 d](/filings/0000874761-26-000063.md) | [287](/filings/0000874761-25-000035.md) | [392 d](/filings/0000874761-25-000075.md) | [985 d](/filings/0000874761-25-000084.md) | [1,088 d](/filings/0000874761-26-000063.md) | [545](/filings/0000874761-26-000120.md) | [976 d](/filings/0000874761-26-000144.md) | [1,297 d](/filings/0000874761-25-000084.md) | [1,488 d](/filings/0000874761-26-000063.md) | [1,201](/filings/0000874761-26-000120.md) | [1,046 d](/filings/0000874761-26-000144.md) |
| Capital expenditure | $m | [1,899 d](/filings/0000874761-24-000070.md) | [2,429 d](/filings/0000874761-26-000063.md) | [2,148](/filings/0000874761-25-000035.md) | [1,685 d](/filings/0000874761-25-000075.md) | [1,832 d](/filings/0000874761-25-000084.md) | [1,727 d](/filings/0000874761-26-000063.md) | [1,254](/filings/0000874761-26-000120.md) | [1,332 d](/filings/0000874761-26-000144.md) | [1,808 d](/filings/0000874761-25-000084.md) | [1,535 d](/filings/0000874761-26-000063.md) | [1,766](/filings/0000874761-26-000120.md) | [1,643 d](/filings/0000874761-26-000144.md) |
| Dividends paid | $m | [111 d](/filings/0000874761-24-000070.md) | [111 d](/filings/0000874761-26-000063.md) | [116](/filings/0000874761-25-000035.md) | [122 d](/filings/0000874761-25-000075.md) | [123 d](/filings/0000874761-25-000084.md) | [122 d](/filings/0000874761-26-000063.md) | [125](/filings/0000874761-26-000120.md) | [125 d](/filings/0000874761-26-000144.md) | [126 d](/filings/0000874761-25-000084.md) | [125 d](/filings/0000874761-26-000063.md) | [125](/filings/0000874761-26-000120.md) | [126 d](/filings/0000874761-26-000144.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2022 (2022-09-30) | Q2 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q2 FY2023 (2023-09-30) | Q2 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [711](/filings/0000874761-23-000080.md) | [712](/filings/0000874761-24-000038.md) | [669](/filings/0000874761-24-000054.md) | [712](/filings/0000874761-24-000070.md) | [712](/filings/0000874761-25-000035.md) | [713](/filings/0000874761-25-000075.md) | [713](/filings/0000874761-25-000084.md) | [713](/filings/0000874761-26-000120.md) | [712](/filings/0000874761-26-000144.md) | [714](/filings/0000874761-25-000084.md) | [715](/filings/0000874761-26-000120.md) | [715](/filings/0000874761-26-000144.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 713,438,630 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0000874761-26-000144.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.